Protocol: Pentoxifylline optimal dose finding trial in preterm neonates with suspected late onset sepsis (PTX-trial)
Abstract Background Late onset sepsis is a leading cause of death and morbidity in preterm infants. Despite optimal antibiotic treatment, sepsis related mortality and morbidity is still high. Pentoxifylline (PTX) is a methylxanthine with promising immunomodulatory properties, which can be used as an...
Saved in:
Main Authors: | Serife Kurul (Author), H. Rob Taal (Author), Robert B. Flint (Author), Jan Mazela (Author), Irwin K. M. Reiss (Author), Karel Allegaert (Author), Sinno H. P. Simons (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Some Variables Affecting the Formulation of Pentoxifylline (PTX) as a Solid Sustained Release Dosage Form
by: Ahmed H. Hussain, et al.
Published: (2017) -
Some Variables Affecting the Formulation of Pentoxifylline (PTX) as a Solid Sustained Release Dosage Form
by: Ahmed H. Hussain, et al.
Published: (2017) -
Editorial: Precision Medicine in Neonates
by: Karel Allegaert, et al.
Published: (2021) -
Neonatal Clinical Pharmacology
by: Karel Allegaert, et al.
Published: (2024) -
Suspecting neonatal severe primary hyperparathyroidism in late onset neonatal sepsis
by: Naseer Yousuf Mir, et al.
Published: (2022)